A recent study compared weight lifters who used steroids to those who did not and found significantly greater cardiovascular damage among the steroid users.
We recruited 140 experienced male weightlifters 34 to 54 years of age, comprising 86 men reporting ≥2 years of cumulative lifetime AAS use and 54 nonusing men. Using transthoracic echocardiography and coronary computed tomography angiography, we assessed 3 primary outcome measures: left ventricular (LV) systolic function (left ventricular ejection fraction), LV diastolic function (early relaxation velocity), and coronary atherosclerosis (coronary artery plaque volume). Compared with nonusers, AAS users demonstrated relatively reduced LV systolic function and diastolic function. In addition, AAS users demonstrated higher coronary artery plaque volume than nonusers. Lifetime AAS dose was strongly associated with coronary atherosclerotic burden in rank of plaque volume for each 10-year increase in cumulative duration of AAS use.